Goniodysgenesis variability and activity of CYP1B1 genotypes in primary congenital glaucoma
Author(s) -
María Teresa García-Antón,
Juan J. Salazar,
Rosa de Hoz,
Blanca Rojas,
Ana I. Ramı́rez,
Alberto Triviño,
JoséDaniel ArocaAguilar,
J. García–Sánchez,
Julio Escribano,
José M. Ramı́rez
Publication year - 2017
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0176386
Subject(s) - cyp1b1 , glaucoma , genotype , blindness , ophthalmology , trabeculectomy , biology , phenotype , genetics , medicine , pathology , gene , optometry , cytochrome p450 , metabolism
Mutations in the CYP1B1 gene are currently the main known genetic cause of primary congenital glaucoma (PCG), a leading cause of blindness in children. Here, we analyze for the first time the CYP1B1 genotype activity and the microscopic and clinical phenotypes in human PCG. Surgical pieces from trabeculectomy from patients with PCG (n = 5) and sclerocorneal rims (n = 3) from cadaver donors were processed for transmission electron microscopy. Patients were classified into three groups depending on goniodysgenesis severity, which was influenced by CYP1B1 enzymatic activity. The main histological changes observed in the outflow pathway of patients with PCG and mutations in CYP1B1 were: i) underdeveloped collector channels and the Schlemm’s canal; ii) abnormal insertion of the ciliary muscle; iii) death of the trabecular endothelial cells. Our findings could be useful in improving treatment strategy of PCG associated with CYP1B1 mutations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom